Gold vs US Dollar

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Corcept Therapeutics Inc (CORT)
Corcept Therapeutics Inc (CORT) Financials

CORT Corcept Therapeutics Inc

66.91

0.00 (0.00%)

Pre Market

Last Updated: 09:13:31

Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Annual Quarterly

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	103.06M	105.65M	117.72M	123.6M	135.41M	146.81M	163.8M	182.55M
Operating Income	8.5M	14.85M	29.58M	31.18M	31.67M	29.5M	35.59M	46.6M
Pre Tax Income	24.28M	18.43M	32.93M	36.38M	36.81M	34.99M	41.6M	52.94M
Net Income	16.6M	15.88M	27.53M	31.38M	31.36M	27.76M	35.49M	47.21M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	0	0	0	0	0	0	0	0
EBIT	22.5M	14.85M	29.58M	31.18M	48.94M	29.5M	35.59M	46.6M
EBITDA	8.68M	15.03M	29.77M	31.29M	31.78M	29.57M	35.72M	46.92M

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	81.32M	159.2M	251.25M	306.49M	353.87M	365.98M	401.86M	482.38M
Operating Income	10.18M	52.86M	89.5M	111.61M	128.2M	124.48M	98.63M	107.28M
Pre Tax Income	8.14M	52.81M	92.15M	116.68M	131.6M	125.01M	116.19M	124.56M
Net Income	8.14M	129.12M	75.41M	94.18M	106.01M	112.51M	101.42M	106.14M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	0.072	1.126	0.656	0.822	0.908	1.062	0.94	1.03
EBIT	10.18M	52.86M	89.5M	111.61M	128.2M	124.48M	112.63M	124.56M
EBITDA	10.27M	52.96M	89.73M	112.31M	128.73M	125.55M	99.42M	107.86M

Corcept Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions